The AF@AuNCs exhibit effectiveness in inhibiting both tube formation and migration of the endothelial cells in vitro since the interaction between vascular endothelial growth factor receptor 1 (VEGFR1) and its ligands could be blocked by AF and the expression of VEGFR2 could be downregulated (as shown in Figure 7a). Here, KDR is linked to atrial fibrillation.